KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to -$1.7 billion.

  • Bristol Myers Squibb's Cash from Investing Activities fell 67716.89% to -$1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.9 billion, marking a year-over-year increase of 8724.56%. This contributed to the annual value of -$21.4 billion for FY2024, which is 83037.04% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Cash from Investing Activities of -$1.7 billion as of Q3 2025, which was down 67716.89% from -$473.0 million recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Cash from Investing Activities peaked at $1.2 billion during Q4 2022, and registered a low of -$19.6 billion during Q1 2024.
  • Its 5-year average for Cash from Investing Activities is -$1.5 billion, with a median of -$329.0 million in 2023.
  • In the last 5 years, Bristol Myers Squibb's Cash from Investing Activities skyrocketed by 20249.38% in 2022 and then plummeted by 924190.48% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Cash from Investing Activities (Quarter) stood at $401.0 million in 2021, then skyrocketed by 202.49% to $1.2 billion in 2022, then crashed by 210.96% to -$1.3 billion in 2023, then skyrocketed by 85.44% to -$196.0 million in 2024, then plummeted by 768.37% to -$1.7 billion in 2025.
  • Its last three reported values are -$1.7 billion in Q3 2025, -$473.0 million for Q2 2025, and -$499.0 million during Q1 2025.